News
Art Krieg was named CEO. Checkmate Pharmaceuticals came out of stealth mode this week with Art Krieg as its CEO, announcing that it had raised $20 million from Sofinnova Ventures and venBio and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback